INTRODUCTION
One of the most interesting concepts in the study of host-pathogen relationships is the subject of viral latency. The elucidation of the mechanisms regulating the establishment and maintenance of animal virus latency has been a tedious process, with definitive explanations still forthcoming. Yet, the importance of this topic is becoming increasingly apparent, since a latent virus may provide the inoculum needed to establish a variety of acute recurring infections and perhaps initiate and maintain an oncogenic process.
Two types of mammalian viruses, herpes simplex virus type 1 (human herpesvirus 1, HSV-1) and herpes simplex virus type 2 (human herpesvirus 2, HSV-2), have received significant consideration regarding viral latency (196, 216, 217, 245) . Pathologically, HSV-1 is commonly involved in lesions above the waist and HSV-2, which appears to be venereally transmitted, is primarily associated with genital lesions (121, 132, 177, 211, 267) . So common is infection by these viruses that exposure to them occurs in most of the population at an early age, resulting in a variety of primary infections. In the majority of these cases, the virus will assume a position of latency and infections recur in three-quarters of those so afflicted (216) . Most of these recurring infections bring only minor discomfort, although both HSV-1 and HSV-2 have the capability of inflicting serious damage, including encephalitis (239) , blindness (31) , and possibly cancer (136, 137) . Indeed, the virus needed to bring about these maladies may be provided endogenously by latent HSV.
In this review, we shall attempt to organize recent reports on the latency of HSV based on previously proposed hypotheses. Beginning with factors that tend to suppress herpetic infections, we shall then follow the virus through the various aspects of the latent state and conclude with a discussion of current methods of treatment and the potential involvement of HSV in the oncogenic process. Hence, by clarifying the various facets of the topic of HSV latency, we hope to bring into focus the current advances and problems in this area, and in so doing assist investigators of this enigma.
ESTABLISHMENT OF A LATENT STATE
Latency may be defined as that state in which a virus remains present within an individual without initiating any overt infection. It seems difficult to reconcile the existence of a latent state with a virus known for the rapidity with which it replicates and destroys its host cell. Thus, it would appear that the most likely explanation for HSV to enter this period of quiescence, after having established a succesful. focus of infection, is that conditions have arisen or intensified in the milieu such that the surrounding environment is no longer conducive to the production of new virions. Indeed, the host immune response is a prime agency for effecting such a change, for, when it is impaired with immunosuppressive therapy 337 on October 16, 2017 by guest http://mmbr.asm.org/ Downloaded from (112, 153) or immunosuppressive disorders (7) , an increase in the number and/or severity of lesions due to HSV recurrences is often noted. Accordingly, the Wiscott-Aldrich syndrome, which is accompanied by an alteration in both the humoral and the cell-mediated immune systems, has been associated with recurrent HSV infections (48) . Also, in an article dealing with cellular immunity and viral infections, Glasgow (88) reviewed several investigations which relate the appearance of herpetic infections with an impaired immune mechanism, especially defective cell-mediated immunity. Hence, to appreciate the role of the entire immune system in the establishment of viral latency, it is necessary to consider briefly the individual components of the "anti-herpes defense system" and, to a certain extent, the manner in which they respond to herpetic infections.
Among the first components of the immune system to arrive at the site of a recurrence are the humoral antibodies whose presence may serve to limit HSV activity (84) . These antibodies, coupled with complement, are able to neutralize or destroy virus or infected cells containing virus-specific antigens (29, 60, 97, 113, 175, 214, 258, 266) . Furthermore, some studies have suggested that IgA, the secretory immunoglobulin associated with mucous surfaces (22) , may also play a role in HSV containment in mucosal tissue (60, 158, 175, 252) . Moreover, the complement-antigen-antibody union mediates the release of anaphylatoxin or similar products, and produces a chemotactic factor, which may result in leukocytic infiltration of the affected area (28, 166, 169, 240) . By adhering to the endothelium in large numbers, leukocytes may wall off the viral lesion and thus help to localize the infection (60) . Macrophages then migrate into the infected tissue where some appear to be abortively infected by HSV (244) , and in this unusual manner they may help to prevent the spread of infection.
Also in cases of recurrent infection, thymusderived sensitized lymphocytes (T-cells) possess the capability of recognizing and responding to stimulation by either HSV-1 or HSV-2 antigens with a high degree of specificity (219, 220) . These activated lymphocytes may also release a nonspecific cytotoxin and a macrophage migration-inhibiting factor (MIF; 90), both of which may assist in HSV containment.
Support for this concept was recently provided by Wilton et al. (263) , who suggested that the absence of MIF and lymphoycte cytotoxin may predispose the cells to the establishment of recurrent infections. Furthermore, lymphocytes, independently or in concert with macrophages, may produce interferon, resulting in reduced or limited viral replication in neighboring uninfected cells (60, 71, 93, 210) . In this regard, studies of herpetic encephalitis and conjunctivitis have established both the prophylatic and therapeutic results achieved by interferon in HSV-initiated disease processes (23, 26, 40, 130, 172, 198, 204 ). Yet, conflicting reports by others suggest that HSV may be somewhat resistant to the effects of interferon (95, 183, 189, 230, 231, 255) .
According to the studies of Lodmell et al. (152) , both the humoral and the cellular immune systems must operate together in a synergistic fashion to suppress HSV infections. The possibility of such enhanced dual action has gained support from the in vitro work of Ennis, who observed a similar phenomenon (69) . These results suggest that neither system alone possesses the capability of terminating the infection. However, when both systems are operating efficiently in association with the inflammatory response, the virus is unable to replicate. Unless it is transmitted to a new host by the unwitting assistance of the infected individual, the virus faces eventual destruction if it continues on its normal course. Therefore, the maintenance of maximum replication potential requires that an apparent latent state temporarily take effect. Then, when the cellular environment is more amenable, the virus can reappear and begin the replication sequence anew.
POSSIBLE MECHANISMS OF LATENCY
Having entered the latent state, in all likelihood as a result of the pressure exerted upon it by the body's defense system, the virus may be visualized as existing in one of two possible conditions, as set forth by Roizman (216 These studies also underlined the importance of genetically determined factors (95, 96) as well as antibody (184) in the maintenance of this dynamic state of cell-virus coexistence. Although the mechanism responsible for maintaining a cell-virus equilibrium is undefined, these systems apparently provide the prerequisites required to establish a chronic cell-virus interaction (indeed, establishment of chronic herpes infection has been observed even when simian virus 5-infected cultures were superinfected with HSV [16] ).
An outgrowth of these and other studies was the recent discovery that defective herpes particles generated during a productive infection may be capable of partial interference with the viral replicative cycle (21, 30) . Such interference could conceivably result in the termination of acute infections and in the establishment of chronic infections (100, 183) , for these particles may induce interferon production or directly interfere with superinfection by HSV, resulting in a controlled but persistent viral infection characteristic of the dynamic state (100, 183 (216) . This substance may be interferon or another inhibitory product. Interestingly, extracts which can inhibit the replication of HSV have been obtained from malignant lymphoma cells (206) as well as hamster cells transformed by HSV-2 (64).
It is implicit within the definition of the static state that infectious virus is not observed in the vicinity of infection during quiescence. However, the static state does not necessarily imply a completely inactive viral genome, since latent viruses at times reveal their presence through specific markers. It is the detection of virusspecific products in the absence of infectious virions which often serves to reveal the presence of either part or all of the viral genome and, in this manner, the existence of a static state virus. For example, both simian virus 40 (SV40) and adenovirus induce virus-specific nonvirion-associated proteins (e.g., T-antigen) in transformed cells even though infectious virus is usually absent (24, 87, 111) . Such an antigen has yet to be described for HSV, but the day may not be far removed when the existence of a herpesvirus T-antigen is established. At present there are reports suggesting that herpesvirus nonvirion antigens do indeed exist (9, 108, 227) . In fact, it has been demonstrated that thymidine kinase, an early enzyme which may be specific for HSV (187) , was present in mouse cells (173) and in human cells (55) abortively infected with this virus. These studies may represent a stable association of at least some of the viral genes with the host cell in the absence of infectious virus. In addition, in vitro studies indicate that HSV nucleic acids (47) (243, 245, 246) could demonstrate infectious HSV in ganglia of latently infected mice and rabbits during quiescence, but only after these ganglia had been excised and maintained as organ cultures for several days. Moreover, Nii (184) has encountered the static state in an HSV-infected cell system, where no infectious virus was demonstrable for a period of several months before reactivation. The culmination of this line of experimentation was reported by O'Neill et al. (191) , who were able to suppress HSV-2 infection in human embryonic lung cells with cytosine arabinoside (ara-c), an inhibitor of deoxyribonucleic acid (DNA) synthesis (149) . During this period of quiescence, the virus was still present, but in a noninfectious form. However, several days after the removal of ara-c, fully infectious HSV-2 reappeared. Hence, it appears as if these investigators had artificially produced, maintained, and terminated a static state system in vitro.
The form HSV assumes while in a nonreplicating state is unknown. Because of the lack of evidence supporting the concept that the complete virion is present within a cell, many investigators have assumed that during the static state the virus exists solely as nucleic acid. Thus, the problem becomes one of determining whether viral nucleic acid exists in an integrated state (i.e., covalently attached to the host's chromosomal DNA) or in a nonintegrated state (i.e., not attached to the chromosomal DNA and possibly existing as an episomal factor). Most work in this area has been done on viruses which have proven to be more amenable to characterization than has HSV. As might be expected, bacteria provided the earliest and most abundant data on integrated phage genomes (80, 147, 264) (185) , have provided strong evidence for the existence of the EBV genome within the nucleus of malignant lymphoma cells.
As can be seen from the above data, most of the work on the location of the viral DNA during latency has involved the host cell's nucleus. At present there is no evidence supporting the idea that a herpesvirus exists in a latent state as an extranuclear episomal factor. However, the above-mentioned studies on the relationship between EBV DNA and the nucleus do not clearly indicate whether a herpes genome is capable of existing in an integrated state. Yet, with respect to this latter point, it may be significant that characteristic breaks at certain regions of chromosomes in HSV-infected leukocytes have been reported (12) . These breaks may only signify weak points in the chromosomal structure (248) , but then again they may represent points from which integrated pieces of viral DNA have been activated. In this regard, Frenkel et al. (81) and Roizman and Frenkel (218) , using nucleic acid hybridization, examined the virus-free tissue of a cervical carcinoma for the presence of HSV-2 genetic material. Their studies revealed that approximately 40% of the HSV-2 genome was present and is covalently linked to the host chromosomal DNA. Although this indicates that some HSV DNA can exist in an integrated state, it has yet to be shown that an entire nondefective HSV genome can remain in this condition. Also, the problem of whether a latent HSV genome exists as the intact duplex or as a single strand of DNA remains to be clarified, since both possess infectivity (237) .
Finally, it should be mentioned that the existence of either a dynamic state or a static state does not rule out the presence of the other in a given individual or population. As described above, experimental data exist to support both states, and the work of Nii (184) 
Eye
In work performed on rabbits subject to recurring herpes keratitis, a herpesvirus was isolated or identified during periods of quiescence in ocular secretions, corneal stromal cells, the lacrimal gland, and the Harderian gland (57, 128, 145, 202, 250 ). Yet, in a similar study Nesburn et al. (180) were unable to recover the virus in any specific eye tissue or associated gland except in organ cultures of the trigeminal ganglion. As previously mentioned, Kaufman et al. (129) , working with human subjects, noted that HSV was present in the tears of individuals who did not exhibit herpetic lesions; this fact, in conjunction with his experiments on rabbits, suggested that the lacrimal gland may be the site of chronic HSV multiplication in humans (129) . In a more recent report, Dawson et al. (58) were able to locate viral particles in human corneal stromal cells, and they raised the possibility that this mesodermally derived tissue may harbor the latent virus. This latter study does not, of course, preclude the possibility that HSV may simultaneously or alternatively reside in lacrimal glands.
Oral Cavity-Site of Recurrent Infections The majority of work relating to the identification of the location of a latent virus involves the oral cavity (221 (226) . However, skin excision experiments from other anatomical locations demonstrate that HSV usually does not remain at the exact site of recurrent infection during periods of quiescence (4, 242) . This may be due to pressure exerted at the recrudescent site by the immune system during the acute infection, which might destroy all virus at the infection site and leave only that virus located in nearby tissues.
Non-Neural Tissue in the Vicinity of Recurrent Infection The isolation of HSV from oral secretions of healthy individuals (32, 65, 128) provides the initiation point for attempts to localize the site where this virus is produced, since this location is believed to be synonymous with the focus of latency (i.e., the cell [s] harboring the latent virus). It was obvious from these studies that the virus released from the sheltering tissue must have relatively facile access to the oral cavity if it were indeed the inoculum used to establish the recurrent infection. Although it appears that some virus-harboring tissue may release virions for long periods of time (6), thus facilitating the detection of the sheltering region, many tissues have been implicated as harboring sites, and at present no conclusive data pinpointing the specific location of the latent virus in humans can be presented.
With regard to suspected latency foci, Douglas and Couch (65) have suggested that HSV may be intimately associated with the salivary glands (even though attempts to isolate HSV from parotid gland secretions proved unsuccessful) or with cells of the oropharynx (151) . In support of the latter possibility, HSV has been secured from pharyngeal washings of adults with upper respiratory illness (167, 170) as well as from the nasopharyngeal region of healthy infants and young children (229) .
In addition, HSV has been found deeper in the respiratory tract. Herout et al. (101) , after studying autopsy samples, identified HSV in tracheal, bronchial, and alveolar specimens. Other studies of individuals with respiratory illness yielded similar results (94, 194, 195) . However, Lindgren et al. (151) , who isolated HSV in 5% of a random distribution of individuals with respiratory infections, suggested that HSV is rarely the causative agent of respiratory illness, but that HSV-bearing respiratory secretions may provide the inocula needed to initiate recurrent infections. Consequently, HSV has been isolated from a number of areas in the oral cavity and the respiratory tract. Unfortunately, none of these regions can be clearly designated as the major shelter for the latent virus. The possibility exists that the several locations mentioned above can serve with equal efficiency as foci of latency.
Yet, these experiments indicating the presence of a virus in vicinal areas have one basic shortcoming; namely, they fail to account for the fact that recurrences often take place at the same site (125, 235) . If the virus were in a gland or respiratory passageway during latency, one would expect eruptions to take place anywhere in the vicinity of the virus-harboring tissue. Hence, one would not expect to find a preponderance of apparent recurrences taking place in one particular location. One possible explanation is that, during latency, the virus exists at a site which has direct and/or specific access to the location of the recurrences. Such a tissue might be the stratum germinativum proximal to the site of recurrent infection or in the neighboring nerve network (196) .
Neural Tissue and HSV Herpes simplex virus may be considered a neurotrophic virus (141, 142) , and it has been implicated in several neural disorders (27, 99, 120, 156, 162, 215, 241, 257) . Although HSV is regarded as a rather neurovirulent virus (13, 155, 157, 190, 222) , it has been shown that some herpesviruses, including HSV, may replicate within the nervous system while causing little or no visible damage (62, 201, 202) . Since nerve cells are unique in that they do not reproduce in the adult and have a long life span, a temporarily inactive virus would be able to survive within a nerve, with little risk of being lost through cell death or division. Hence, nearby nerve cells could provide an excellent site in which to establish a focus of latency.
Because primary and recurrent HSV infections of the facial area occur in the superficial layers of the skin, the virus is closer to peripheral nerves than it is to main nerve branches. Thus, one would expect the virus to enter the nervous system by way of a terminal nerve pathway. Studies have demonstrated that the virus can migrate centripetally along terminal nerve endings after initial infection (119, 174, 236, 262 ). Yet, conflicting reports exist with regard to whether the virus travels mainly through the axon (62, 105, 143) or through the nerve-supporting cellular network (13, 20, 119, 205, 236) , for available evidence supports both of these migratory pathways. Since the peripheral nerves of the face eventually lead to the trigeminal nerve (the fifth cranial nerve) which in turns forms the trigeminal ganglion (also known as the Gasserian or semilunar ganglion), it follows that upsetting the physiological balance anywhere within this nerve tract might disturb a cell-virus association (assuming the virus is present within this tissue), such that a herpetic infection would recur. Evidence favoring this concept originates from cases in which a trigeminal sensory root rhizotomy was performed on individuals with intractable neuralgia; it was found that a large percentage of these patients displayed herpetic vesicles in the area innervated by the branches of this nerve (particularly by the second and third branches; 36, 68). Furthermore, herpetic vesicles are not found and cannot be induced in denervated skin (35, 68) . Consequently, these results suggest that the trigeminal nerve network or one of its components may in fact shelter a herpesvirus.
The ganglion of the trigeminal nerve has been considered the primary site for a latency focus, since from experimentation on animals it is well established that HSV can remain latent in the sensory ganglia (15, 180, 243, 246, 247) . Moreover, studies on human trigeminal tissue resulted in the recovery of HSV from this ganglion, but not from other areas of the trigeminal nerve network (14, 17) . These results have led Paine (196) and Stevens and Cook (246) to propose the trigeminal ganglion as the sheltering site for the latent virus. Furthermore, Schwartz and Elizan (233) have suggested that glial cells, which are also associated with the ganglia, may be the specific harboring site of the latent virus. According to these investigators, when glial cells fuse with neurons, the viral replicative cycle is activated and the released virus may then initiate a reinfection. This concept might derive support from Stevens and Cook's (246) ability to recover virus only from intact ganglia but not from specific cells of the ganglia. Unfortunately, one now encounters a difficulty that was mentioned previously; that is, if the virus resides in the Gasserian ganglion, one would not expect to find the majority of recurrences taking place at the same location; rather, they should occur with equal frequency in all areas within the sphere of influence of this ganglion (i.e., the face; 36). Yet, if one postulates that HSV remains dormant in the peripheral nervous system (162) , a dilemma appears. Although a peripheral residence would explain the specificity of the infection site, it does not account for the fact that virus is recoverable only from the ganglia (17, 246) . On the other hand, it has been shown by in vitro studies that all cells in the nervous system are capable of supporting HSV replication (74, 148 
REAPPEARANCE OF INFECTION
Having considered the commencement of latency, the possible forms of the latent state, and the suspected locations of the latent virus, one may now inquire about the nature of the agents responsible for the onset of recrudescence. A great deal of research in this area has dealt with recurrent herpetic infections of the lip and oral cavity (i.e., cold sores or fever blisters). One inducer of fever blisters is of course fever, whether artificially induced or occurring "naturally" (43, 259) . However, this in itself is somewhat perplexing since several recent publications have demonstrated that HSV replicates poorly in vitro at elevated temperatures (50, 51, 85, 107) . The explanation for this discrepancy may lie in the fact that the virulence of HSV is correlated with its ability to grow at a higher than normal temperature (37) . In other words, the better a particular virus can replicate at an elevated temperature (e.g., during a fever), the greater potential it possesses for initiating an infection. Thus, only the more heat-resistant strains of any given HSV type would replicate well during a fever. Such interstrain variations with respect to temperature sensitivity may explain the method by which HSV, noted for its intolerance of elevated temperature, can continue to replicate during a fever, but this does not, of course, indicate the viral structures or functions responsible for conferring heat resistance. An interesting hypothesis, put forth by 343 VOL. 38, 1974 With respect to this latter point, it is interesting to note that Lwoff has taken into account the physiological condition of the host cell. Whereas attention is generally directed toward the virus during the onset of infection, the host's response to the latent virus cannot be ignored, since it could conceivably be altered by adverse conditions including fever. Hence, any specific control which the body's defense system or an individual cell has over the virus during latency could be affected in such a manner that the formation and release of large numbers of infectious viral particles would result. Noteworthy in this regard is Herriott's proposal which suggests that an infected cell may release viral nucleic acid into the extracellular environment, where it is normally incapacitated by humoral nucleases (102) . However, during a fever the nuclease activity may be hampered by a deoxyribonuclease inhibitor released from leukocytes (103) . When this occurs, free viral nucleic acid is then able to spread and infect surrounding tissues, which results in the reappearance of herpetic vesicles. Although this is an interesting concept, it has yet to receive direct experimental support and requires further development to account for the fact that not all febrile illnesses induce acute herpetic infection with equal frequency (75) .
Of course, in addition to viral nucleic acid, it is probable that antigenic viral particles are also released from some sites of latency, since an increased rate of recurrence takes place soon after impairment of the host immune system, as previously noted. Thus, reduced levels of immunoglobulin (252), immunosuppressive hematological disorders (7, 39, 106) , the administration of immunosuppressive drugs (112, 146, 153) , and possibly steroid therapy (134, 188) , all of which have been shown to result in immunological deficiencies, would allow a latent virus to establish a focus of acute infection. The modus operandi of an immunological disorder in causing a recrudescence can be understood by visualizing a host-virus equilibrium (i.e., a type of dynamic state) regulated by the immune sys- tem. An impairment of this regulatory mechanism could create an imbalance in the equilibrium favoring the virus moiety and result in an apparent infection.
The relationship between a static state virus and the immune system is not as amenable to interpretation. If the static state exists, then the effect of an agent which induces viral replication may be more indirect, although at present the sparsity of data relating to this point precludes speculation.
Other factors which may bring about the reappearance of a herpetic infection include trigeminal nerve rhizotomy (36, 68) , pesticides (249) , trauma (160, 178) , anaphylactic shock (89), the Arthus reaction (3), adrenalin (232) , pituitary hormones (76), menstruation (234), streptococcal infection (33), excessive exposure to cold, wind, or sunlight (76) , and ultraviolet light (216) . Also implicated as possible stimulators of a latent herpesvirus are multiple sclerosis (38, 52) , nasopharyngeal carcinoma (77, 197) , and even Cannabis spp. (122) . Interestingly, several reports have suggested that emotional stress (115) as well as depression (213, 225) may precipitate recurrences (however, in a recent report by Pokorny et al. [2031 such claims were not substantiated). The exact mechanisms of operation of these factors in inducing recurrent herpetic eruptions are for the most part unknown. It is possible that these agents may assist a dynamic state virus by weakening the resistance of the cells subject to HSV infection, thus making these cells more "permissive" to reinfection (216) . However, if the latent virus is in a static state, then these agents may act either directly or indirectly on the virus, in order to initiate its replicative cycle.
One may ponder whether in fact these recurrent eruptions are nothing more than new infections caused by recontact with the virus from the external environment, rather than the reactivation of a latent virus. Current evidence seems to weigh heavily against this idea, for, if these later infections were caused by virus from an external source, it is unlikely that they would occur mainly in the same specific regions where past herpetic eruptions have taken place (125, 234, 235) . If the inocula were provided from the environment, it would be especially difficult to rationalize the fact that emotional stress can precipitate an outbreak (115), or to explain the manner in which psychotherapy can effect a cessation of recurrences (25) . Thus, the most suitable explanation for these observations is that HSV exists in a state of latency which provides the virus needed to establish a recurrent infection. (179, 231, 260) , interferon (126) , ara-c (109), ara-c with L-asparaginase (34), arabinofuranosyladenine (138, 200) , phosphonoacetic acid (238), adenine arabinoside (45, 199) , rifamycin (181), ethyl ether (186), various photodynamic dyes (1C4), X irradiation (7, 139), a vaccinia virus vaccine (72), a herpesvirus vaccine (127, 251) , cryotherapy (19, 83, 104) , and psychotherapy (25) . However, HSV has proven to be resistant to glutathione (124), fl-methazone (124) , pyran copolymers (231), lysozyme (124), 6-azauridine (138) , and kethoxal (256) .
Of the above listed efficacious drugs, two have gained fairly wide appeal in clinical practice. IudR, which has been shown to inhibit HSV in vitro (116, 124, 200, 207, 231) , has yielded promising results in the treatment of herpes encephalitis (18, 44, 160, 165, 254) and herpetic keratitis (5, 53, 61, 261) . Similar results have been obtained with ara-c both in vitro (78, 193, 207) and in the treatment of a variety of herpetic eruptions (109) including oral lesions (158) and herpes encephalitis (73, 86, 257) . Of the two drugs, ara-c is slightly favored, because of the ease of administration and its reduced toxicity to the host (73, 109) , even though it may synergistically act with HSV to effectuate increased chromosomal damage (192, 193) . Also, recent studies indicate that the therapeutic effects of IudR therapy may not be as beneficial as earlier thought (46, 59, 63, 70, 79, 118, 133, 257) . Thus, chemical therapy alone has yet to provide a clinically proven, potent but safe agent for treating herpetic recurrences, and so other approaches have been investigated.
One of the more successful innovations used to combat HSV infections has been the combined administration of both chemical and physical agents in the suppression of herpetic lesions. The chemicals are often photodynamic dyes such as proflavine (164, 168) and neutral red (82, 164) , although IudR has also been tested (53) , which are used in conjunction with fluorescent, incandescent, or ultraviolet light. Although the results of clinical trials have been encouraging (131) , this method of treatment has resulted in an inadvertent yet serious oversight. With the gradual delineation of the agents responsible for activating the oncogenic potential of the herpesviruses, it is becoming apparent that these methods of treatment resemble the procedures used to demonstrate the malignant transforming ability of HSV in vitro. For example, the oncogenicity of HSV was first demonstrated by the transformation of hamster cells in vitro with ultraviolet light-irradiated virus (66, 208) , and yet ultraviolet light is currently being utilized, in combination with IudR, to treat recurrent herpetic lesions (53) . Furthermore, a procedure similar to neutral red-fluorescent light therapy has recently been used to transform hamster cells oncogenically in vitro (150, 209) .
However, it must be emphasized that, although in vitro studies can provide valuable information pertaining to the mechanics of various cell systems, the results obtained do not necessarily correlate to a significant degree with actual in vivo events. Obviously, more work is needed to substantiate any relation between the results of these transformation experiments and therapeutic regimens. Follow-up studies of the incidence of cancer in individuals who have received dye-light therapy for herpetic infections would be the next logical step to determine whether a danger does indeed exist, yet these procedures may be of too recent origin to obtain statistically significant epidemiological data.
LATENT HSV AND CANCER Although there is no direct proof that HSV is an etiological agent of human cancers, its in vitro transforming ability and oncogenic potential cannot be denied (54, 66, 67) . This latter fact, in conjunction with considerable circumstantial evidence implicating the virus with several types of neoplastic processes, has stimulated research on the possible relationship between HSV and human malignancies (9, 10, 224) . Because of the failure to isolate HSV from a given type of neoplasm, and the observation that viral replication connotes the cessation of cellular macromolecular synthesis and eventual cell death (217) 6 months prior to their spontaneous production of HSV-2 (11) . These data, strengthened by epidemiological studies, suggest that a static state HSV-2 appears to offer a promising subject for those investigating human cancer using a virological approach.
Although considerable evidence is accumulating to associate HSV-2 with uterine cervical carcinoma (176) , little attention has been directed to the possible in vivo oncogenicity of latent HSV-1, even though its carcinogenic capability has been demonstrated in vitro (67 Although these experiments do not prove a viral etiology of human cancer, they do suggest that the relationship between HSV and cancer may be more than just coincidental. This in itself justifies a closer examination of the lifelong and intimate association between HSV and its host cell during the state of latency.
CONCLUDING REMARKS Throughout this review, we have attempted to organize recent reports on the latency of HSV into a coherent body of information. In retrospect, this review may have raised more questions than it has answered, but rather than reiterate the queries and ambiguities that have been presented, it may be more profitable to sketch several promising lines of investigation which the literature cited appears to foreshadow.
The efficacy of interferon in inhibiting HSV infections should be clarified. If it does have therapeutic or prophylactic value, then the use of interferon inducers during herpetic recurrences may be warranted. However, the conflicting data on this point, cited earlier, may suggest an inconsistent response so that interferon may be of value in only some herpetic infections. This varied sensitivity could be due to several factors, including subtle differences in herpes types or subtypes.
The cell(s) in which the virus is sequestered continues to remain an enigma whether one is considering the dynamic or static state. Although it is easy to imagine that research in this area would be best served by more sensitive procedures for detecting infectious virus, it appears that such techniques have resulted in increased controversy. As these procedures have evolved, the virus seems to be present in several areas without specific identification of any one area as the main sheltering site. Perhaps it would be worthwhile to utilize more precise methods to detect virus markers, including nucleic acid hybridization, or to attempt to induce the appearance of viral products in specific cells lacking infectious virus.
Although many agents have been held responsible for the precipitation of recurrent HSV infections, the mechanism of induction may be similar for all. The agents responsible for such recurrences are many and varied, but all have the ability to stress the cells and/or the body, resulting in a physiological imbalance. If the cell is controlling the virus by a suppressive mechanism during periods of quiescence, then an alteration in this control process may result in the reappearance of virus. Whether a cell factor exists and functions in such a manner is unknown, and the stressing of cells in attempts to activate virus have met with minimal success. Some reflection upon these and other comments presented in the body of this review are indicative of the state of affairs regarding HSV latency at this time. The groundwork has been completed, and the basic hypotheses along with relevant data have been set forth. However, continuing research is required before the major factors involved in the establishment of latency as manifested by HSV are finally elucidated, and before effective prophylactic agents can be developed to prevent this bothersome and at times serious threat to human health. 
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